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Summary
Pathogenic strains of Yersinia deploy a type III
secretion system to inject the potent tyrosine
phosphatase YopH into host cells, where it depho-
sphorylates focal adhesion-associated substrates.
The amino-terminal, non-catalytic domain of YopH is
bifunctional; it is essential for the secretion and
binding of the specific chaperone SycH, but also
targets the catalytic domain to substrates in the
infected cell. We describe the 2.2 Å resolution crystal
structure of residues 1–129 of YopH from Yersinia
pseudotuberculosis. The amino-terminal a-helix (2–
17), comprising the secretion signal, and b-strand
(24–28) of one molecule exchange with another
molecule to form a domain-swapped dimer. Nuclear
magnetic resonance (NMR) and gel filtration experi-
ments demonstrated that YopH(1–129) could exist as
a monomer and/or a dimer in solution. The topology of
the dimer and the dynamics of a monomeric form in
solution observed by NMR imply that YopH has the
propensity to unfold partially. The dimer is probably
not important physiologically, but may mimic how
SycH binds to the exposed non-polar surfaces of a
partially unfolded YopH. Phosphopeptide-induced
perturbations in NMR chemical shifts define a
substrate-binding surface on YopH(1–129) that
includes residues previously shown by mutagenesis
to be essential for YopH function.
Introduction
Bacterial pathogens use unique ways to control their
animal and plant hosts. A primary strategy is to modulate
the signal transduction pathways of the host. Many
Gram-negative bacteria, including species of Escherichia,
Salmonella, Yersinia, Xanthomonas and Erwinia, do this
by translocating effector proteins (virulence factors)
directly into the host cell cytoplasm (Finlay and Cossart,
1997; Hueck, 1998; Cornelis and Van Gijsegem, 2000).
Delivery is by a contact-dependent type III secretion
system, termed an injectosome or secreton, which spans
both bacterial and animal cell membranes. A similar type
III system is found in the basal body of bacterial flagella
(Macnab, 1999).
Three Yersinia species – Yersinia pestis, the aetiolo-
gical agent of plague, and Yersinia pseudotuberculosis
and Yersinia enterocolitica that cause gastrointestinal
disorders – encode the injectosome on a 70 kb plasmid
that is absolutely required for virulence. Yersinia translo-
cates six effectors into host macrophages (Hueck, 1998).
One of them, YopH (468 residues), is a modular protein
consisting of a non-catalytic region (residues 1–130) and
a potent tyrosine phosphatase domain (residues 190–
468), which is very similar to eukaryotic enzymes in both
structure and catalytic mechanism (Guan and Dixon,
1990; Zhang and Dixon, 1994; Fauman and Saper, 1996).
YopH was shown to be essential for virulence in mice
(Bliska et al., 1991). By dephosphorylating cytoskeletal
proteins in infected macrophages, it effectively disrupts
phosphotyrosine-dependent signalling pathways necess-
ary for phagocytosis (Bliska et al., 1992; Andersson et al.,
1996). Host protein targets include Crk-associated
substrate (p130Cas), paxillin and focal adhesion kinase in
HeLa cells (Black and Bliska, 1997; Persson et al., 1997),
and Cas/Fyn-binding protein and murine SKAP-HOM in
macrophages (Hamid et al., 1999; Black et al., 2000).
Removal of the amino-terminal domain of YopH
prevents the secretion and translocation of YopH by the
type III system. Using various truncation mutations fused
to a reporter gene, residues 1–17 were identified as
necessary and sufficient for secretion, whereas residues
18–71 were necessary for translocation into the infected
cell (Sory et al., 1995). Unlike type II secreted proteins, the
YopH amino-terminal domain does not share a conserved
signal sequence with other type III secreted proteins, nor is
it cleaved by a signal peptidase. This suggests that the
type III injectosome may recognize a structural motif or
chemical property that is an integral part of the effector
protein’s overall structure. Lloyd et al. (2001) have
suggested that an amphipathic helix may be the
recognition motif. Furthermore, YopH, like many other
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Table 1. Diffraction data and refinement statisticsa.
Crystal Native K2PtCl4 (10 mM, 24 h) UO2Cl2 (10 mM, 24 h) HgCl2 (1 mM, 24 h)
Resolution (Å) 22.0–2.2 (2.28–2.20) 22.0–2.1 (2.18–2.10) 22.0–2.2 (2.26–2.20) 22.0–2.7 (2.80–2.70)
l (Å) 1.5418 1.07142b 1.5418 1.5418
Total measurementsc 68 285 (NAd) 98 870 (NA) 98 744 (NA) 24 038 (NA)
Unique reflectionse 7503 (720) 8520 (785) 7486 (561) 3965 (379)
Redundancye 6.2 (6.1) 6.3 (4.9) 6.7 (6.5) 2.6 (2.7)
Completeness (%) 99.8 (99.9) 98.7 (93.8) 97.2 (73.8) 96.1 (99.2)
,I/sI. 20.8 (16.2) 15.7 (7.2) 23.6 (17.6) 12.9 (5.7)
Rsym 0.050 (0.136) 0.066 (0.223) 0.053 (0.142) 0.081 (0.221)
MIRAS phasing
Resolution (Å) 20–2.2 (2.48–2.20) 20–2.2 (2.48–2.20) 20–2.2 (2.48–2.20) 20–2.5 (2.83–2.48)
Number of sites 2 2 2
Phasing power 1.44 (1.30) 0.98 (0.87) 1.15 (1.19)
Rcullis 0.95 (1.07) 0.91 (1.02) 0.85 (0.92)
% reflections with anomalous differencesf 83.2 (86.4) 85.4 (88.8) –
,|FPH (1)–FPH (–)|./,FPH.
f 0.041 (0.075) 0.047 (0.076)
Anomalous Rcullis
f 0.94 (1.01) 0.92 (0.99) –
Figure of merit 0.46 (0.28)
After density modification 0.66 (NA)
Refinement statistics
Resolution (Å) 22.0–2.2 (2.25–2.20)
Number of reflections
Working set 6732 (461)







r.m.s.d. bond lengths (Å) 0.054






a. Phasing power and R-factors are defined in Drenth (1999). Values in parentheses are for the highest resolution shell.
b. K2PtCl4 derivative data collected at CHESS; this is the absorption peak wavelength. Other data collected on the R-AXIS IV.
c. Bijvoet-related measurements counted separately.
d. NA, value not available.
e. Bijvoet-related reflections/measurements counted as one reflection.






























































type III secreted effectors, must bind a specific chaperone
protein for successful translocation. SycH, one of a family
of acidic type III chaperone proteins, requires residues
20–70 of YopH for interaction (Woestyn et al., 1996). In
Yersinia mutants lacking SycH, YopH accumulates in the
bacterial cytoplasm.
The YopH non-catalytic domain is multifunctional. Black
et al. (1998) showed that, once inside the infected cell, the
amino-terminal domain of YopH binds to phosphorylated
proteins that are in vivo substrates of the phosphatase
domain. This interaction is phosphotyrosine dependent
and is important for efficient targeting of YopH to
substrate. Subsequently, several residues implicated in
this interaction were detected by random mutagenesis
(Montagna et al., 2001).
To understand how YopH is recognized for type III
secretionand translocation, wedescribe the crystal structure
of residues 1–129 of the YopH effector from Y. pseudotu-
berculosis. Unexpectedly, the molecule forms a domain-
swapped dimer that may mimic an intracellular YopH:SycH
complex. Additionally, we have mapped a phosphopeptide
binding site on the protein with nuclear magnetic resonance
(NMR) chemical shift perturbation data. We compare the
results with a recently reported structure from a seemingly
identical crystal form (Evdokimov et al., 2001).
Results
YopH(1–129) forms a domain-swapped dimer
The structure of the amino-terminal, non-catalytic domain
(residues 1–129) of YopH from Y. pseudotuberculosis was
determined by multiple isomorphous replacement with
anomalous scattering. YopH(1–129) is 100% and 98%
identical to its homologues in Y. pestis and Y. enterocolitica
respectively. The model, consisting of residues 2–125 and
110 water molecules, was refined to 2.2 Å resolution with an
R-factor of 0.224 and Rfree¼ 0.258. The crystallographic
results are summarized in Table 1.
YopH(1–129) forms a domain-swapped dimer with a
crystallographic dyad-related molecule (Bennettet al., 1995)
(Fig. 1). Overall dimensions of the dimer are about
54 Å 37 Å 40 Å. Each monomer adopts an a1b struc-
ture containing four a-helices and four b-strands (Fig. 1B).
Residues 2–28, which form the a1-helix and the first half of
the b1-strand, extend away from the rest of the monomer
and interact primarily with the other subunit of the dimer.
Following b1, residues 34–49 form an ordered meander
that lacks apparent secondary structure except for a b-turn
between residues 43 and 46. Following this are two
antiparallel helices, a2 and a3, separated by a short b-
strand (b2). Helix a3 is followed by a b-hairpin composed of
strands b3 and b4. Together with b2, these form a three-
stranded antiparallel sheet that forms a small platform for
the three helices of the core domain. Following b4 is the
a4-helix running parallel toa2 and antiparallel toa3. Thefinal
resolved residue in the structure is Ser-125. Residues 126–
129 and the Ser-(His)6 tag are presumed to be disordered.
Searchesofknown protein folds failed to recognize any other
structures with similarity to YopH(1–129).
The polypeptide regions in YopH suggested to be
essential for type III secretion and translocation (Sory et al.,
1995) are highlighted in Fig. 1B. The secretion segment
(residues 2–17) is simply the a1-helix, whereas the
translocation domain (18–71) is made up of the b1-strand,
the meandering loop, a2 and b2. The meandering loop
(residues 35–49) connects the b1-strand to a2 and is part
of the region shown to be essential for binding the specific
chaperone SycH (Woestyn et al., 1996). Its fold is
maintained by an extensive hydrogen-bonding network
(Fig. 2) primarily involving four residues: Thr-24 (from the
other subunit), Asn-34, Glu-52 and Gln-107. Side-chains
from each of these residues make hydrogen bonds to
main-chain atoms of the loop. Within the loop, there is a
prominent b-turn (43–46) that exposes an Ala and an Ile to
solvent. A major conformational restraint of the loop is a
salt bridge between Glu-36 and Arg-49 that ‘pins’ the loop
together (Fig. 2).
In the dimer observed in the crystal structure, the
b1-strand (24–34) pairs with b1 of the symmetry-related
molecule to form an antiparallel twisted b-ladder with 8–10
interstrand hydrogen bonds. The ‘swapped’ a1-helix (2–
17) packs against a2 and a4 of the other subunit, primarily
through non-polar contacts. The total solvent-accessible
surface of each subunit buried by dimer formation is
< 2540 Å2 representing < 30% of the subunit surface area
(Fig. 3). Approximately two-thirds of this surface is
hydrophobic. The only other intersubunit contacts are
between b1 and a2 and the two amino-termini.
YopH(1–129) exists as a monomer and dimer in solution
The result that YopH(1–129) crystallized as a domain-
swapped dimer was unexpected. Previous studies
demonstrated that full-length YopH was a monomer in
solution (Zhang et al., 1992). Although the full-length YopH
had an apparent molecular weight of 74 000 based on size
exclusion chromatography, sedimentation equilibrium
showed a molecular weight of < 49 000, suggesting an
extended monomer in solution (Zhang et al., 1992).
For crystallization, YopH(1–129) (Mr < 14 800) was
prepared in imidazole buffer at pH 7.2 and crystallized at
pH 8 (see Experimental procedures ). To investigate
whether pH affected the oligomeric structure of YopH(1–
129), cells expressing the same expression construct were
lysed and purified at pH 5.7 with a procedure similar to that
described for the full-length and catalytic domain forms of
YopH (Zhang et al., 1992). Gel filtration of both samples on
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a calibrated Superdex 75 HR 10/30 column showed that
the protein purified at pH 7.2 contained two species with
apparent molecular weights of 29 800 (major peak) and
15 300, whereas the low pH preparation was predomi-
nantly one species with an apparent molecular weight of
13 300 (Fig. 4A). The poor separation of the pH 7.2 species
may reflect a dynamic equilibrium between monomer and
dimer. Nevertheless, further purification of each species
can be achieved, and the two forms are stable at low pH
(J. Vijayalakshmi, data not shown). Dynamic light scattering
Fig. 2. Stereo pair of the meandering loop (35–
49) fold. Atoms are coloured by type: C, yellow;
N, blue; O, red; S, cyan. Light blue carbon
atoms are from the symmetry-related subunit.
Hydrogen bonds are dashed lines, and red
spheres are ordered water molecules. Loop
includes residues involved in peptide binding
and comprises part of the region shown to be
important for binding the SycH chaperone.
Fig. 1. Tertiary fold of YopH(1–129).
A. Domain-swapped dimer observed in the
crystal structure. A crystallographic dyad
(shown by arrow) relates the two molecules that
comprise the dimer.
B. Structure of one subunit with regions shown
previously to be important for secretion (red,
residues 2–17), translocation (gold, residues
17–71) and chaperone binding (20–70) (Sory
et al., 1995; Woestyn et al., 1996). The
secondary structural elements are labelled. The
N- and C-termini are residues 2 and 125
respectively.
C. Omit electron density map (2Fobs–Fcalc,
acalc) contoured at 1s in the region around the
twofold axis relating the two subunits of the
dimer. Gly-29 is the ‘hinge’ residue (Bennett
et al., 1995). In a monomeric structure, the
polypeptide would probably form a reverse turn
at this position (compare with Fig. 7A).
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measurements (data not shown) of the pH 7.2 protein
showed a monodisperse species with hydrodynamic
radius of 2.7 nm, consistent with an apparent molecular
weight of 32 000. Protein prepared at pH 5.7 had a radius
of 2.1 nm, which would correspond to a globular protein of
about 17 kDa (also see below). Interestingly, isoelectric
focusing (data not shown) of the protein purified at pH 7.2
showed five bands with pI values ranging from 7.4 to 8.0
(theoretical pI¼ 8.03), whereas the protein at pH 5.7 was a
single isoform of pI¼ 8.0. These experiments suggest
that, when overexpressed in Escherichia coli, YopH(1–
129) folds into both monomers and dimers, but the
monomeric form appears to predominate at low pH.
Recent results have demonstrated that purified dimer was
stable at all pH values tested, but that the purified
monomer slowly aggregated when shifted to higher pH
(J. Vijayalakshmi, unpublished data).
Because of the ability of YopH(1–129) to form both
monomeric and dimeric forms, we wished to assess
whether the protein in solution had any conformational
flexibility. NMR spin relaxation methods use the 15N–1HN
bond vector as a probe to sense protein backbone
dynamics (Peng and Wagner, 1994). Nitrogen-15 R2
relaxation rates were measured for 15N-labelled YopH(1–
129) at pH 6.5 in phosphate buffer (Fig. 4B). The average
T2 relaxation time (1/R2) for the majority of residues was
90 ms. The mean value for the T1 (1/R1) was 876 ms
(results not shown). From these values, we calculated a
rotational correlation time of 7.1 ns, which corresponds to
Fig. 3. Contact surface between subunits in the YopH(1–129) dimer.
Molecular surface of one subunit showing contacts less than 4 Å (red
surface) with the other subunit (depicted by the blue tube). Prepared in
GRASP (Nicholls et al., 1991).
Fig. 4. Solution studies of YopH(1–129).
A. YopH(1–129) samples were injected into a
Superdex 75 HR 10/30 column connected to a
Waters liquid chromatography system. Trace 1
is protein purified at pH 7.4 by the Ni21-NTA
column, dialysed in imidazole buffer, pH 7.2,
and eluted in the same buffer. The broadness of
the two peaks could mean that interconversion
between monomeric and dimeric forms may be
taking place during the experiment. Trace 2 is
the protein purified at pH 5.7 and eluted with
100 mM NaCl, 1 mM EDTA, 100 mM sodium
acetate, pH 5.7. Peak locations of molecular
weight standards (Sigma) are shown above the
traces and were used to interpolate the
YopH(1–129) protein peak molecular weights.
B. 15N T2 relaxation in YopH(1–129). R2 values
(1/T2) are plotted as a function of residue
number. Error bars reflect experimental errors
in measurement. Missing data points result from
residues that did not have assigned
resonances. Secondary structures assigned
from the crystal structure are shown. Regions
showing higher than average R2 values reflect
conformational averaging and are located
mostly in the loops.
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a hydrodynamic radius of 1.99 nm, using the Stokes–
Einstein relationship (Cavanagh et al., 1996). This number
is in excellent agreement with the hydrodynamic radius of
2.1 nm obtained from the dynamic light scattering studies
at low pH described above and a theoretical value of
1.94 nm predicted for a 14.8 kDa protein, assuming a
single hydration shell and a specific volume of
0.73 cm3 g21 (Cavanagh et al., 1996). This proves that
YopH(1–129) is a monomer of 14.8 kDa in solution at
pH 6.5 or lower, even at the relatively high concentration of
0.9 mM used for the NMR studies.
By examining the R2 values for individual residues
(Fig. 4B), we noted that certain residues, mainly located
between helices a1 and a2 (residues 19–50), showed
considerably greater line broadening of their 15N reson-
ances (up to 15 s21 excess broadening). This indicates
that these regions in the monomeric protein are under-
going conformational exchange (i.e. adopting different
conformations) at the milli- to microsecond timescale. This
conformationally dynamic portion of the monomer corre-
sponds to the domain cross-over region (b1 and the
meandering loop) in the dimer (see Fig. 1B). In contrast,
these residues appear to be static in the dimer observed in
the crystal structure, as they have average crystal-
lographic temperature factors that are even slightly
below those of the entire dimer (,B.¼ 25.7 Å2 for
residues 20–50 compared with ,B.¼ 29.2 Å2 for all
residues).
YopH(1–129) binds tyrosine-phosphorylated peptides
In addition to its role in secretion, translocation and
chaperone binding by Yersinia, the amino-terminal domain
of YopH also binds to proteins in the infected host cell
known to be substrates for the YopH phosphatase domain
(Black et al., 1998). Binding is phosphotyrosine dependent
with specificity similar to that of the Crk SH2 domain.
YopH(1–129) lacks significant sequence or tertiary
structure similarity to other targeting domains such as
the SH2 and PTB domains. The former are present on the
amino-termini of several eukaryotic tyrosine phosphatases
(Hof et al., 1998).
Recently, Montagna et al. (2001) identified four residues
(Gln-11, Val-31, Ala-33 and Asn-34) in the amino-terminal
domain of YopH that were important for binding to
phosphorylated p130cas, an in vivo substrate of YopH.
Residues 31–34 are on the part of b1 that packs against
the a1-helix coming from the other subunit, and Gln-11 is
nearby on the exposed surface of a1 (magenta side-
chains in Fig. 5D). Val-31, Ala-33 and Gln-11 surround a
Fig. 5. Phosphopeptide-binding region on
YopH(1–129). Molecule is rotated < 908 along
the horizontal from Fig. 1A. Only the left half of
the dimer is shown.
A. The solvent contact surface is coloured by
electrostatic potential (red is negative; blue is
positive).
B. The magenta coloured surface indicates the
four residues (Gln-11, Val-31, Ala-33 and Asn-
34) that, when mutated, interfered with binding
to phosphorylated p130Cas (Montagna et al.,
2001).
C. Highlighted in blue are residues of YopH(1–
129) that have perturbed chemical shifts when
YopH(1–129) was titrated with the
phosphopeptide acetyl-DE(pY)DDPF-NH2.
D. Ribbon representation of this portion of
YopH(1–129) showing the location of side-
chains implicated in forming the
phosphopeptide-binding region. Side-chain
colours are as in (B) and (C). Residues 11, 31
and 34 were identified by both NMR and
mutagenesis.
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pronounced pocket formed between a1 and b1 (Fig. 5B
and D). The Gln-11 side-chain also anchors the a1-helix to
the b1-strand through two hydrogen bonds. Although this
is an intersubunit interaction, it would also exist in a
monomeric structure (see Discussion ). Asn-34 is only
partially solvent accessible, but constrains the confor-
mation of the meandering loop by hydrogen bonding to
Thr-37 and Glu-52 (see Fig. 2).
To assess those residues actually involved in phospho-
peptide binding, doubly labelled [15N, 13C]-YopH(1–129)
was titrated with a concentrated solution of the phospho-
peptide acetyl-DE(pY)DDPF-amide derived from murine
SKAP-HOM, a YopH substrate (Black et al., 2000). The
binding process for this peptide is in the slow/intermediate
exchange regime, indicating on- and off-rates of the order of
milliseconds or slower. Residues 8–11, 14–15, 26–28,
30–32, 34 and 49 had chemical shifts that were
significantly different compared with the apoprotein
(Khandelwal et al., 2001) (Fig. 5C and D). Atoms from
these perturbed residues are probably located in the vicinity
of a bound phosphopeptide or have undergone confor-
mational changes to shift their chemical environment.
These residues, of which three were also identified by
mutagenesis, form a wide, mostly electropositive patch
over the surface of a1 and the two b1-strands (Fig. 5A and
D). Notably, six of these 14 residues are positively charged,
appropriate for binding such an acidic peptide. Residues
Arg-14, Leu-15 and Asn-30 surround the pocket containing
Val-31, Ala-33 and Gln-11 mentioned above. Next to this
pocket is a positive depression with Arg-28, Arg-14 and
Arg-10, all of which undergo changes upon peptide binding.
YopH(1–129) and LcrQ are structurally similar proteins
Searching sequence databases (NCBI, September 2000)
with PSI-BLAST failed to detect any other sequence similar
to YopH(1–129) except for two proteins previously
reported to have significant sequence homology: LcrQ
(termed YscM1 in Y. enterocolitica ) and YscM2 (only in Y.
enterocolitica ) (Rimpiläinen et al., 1992; Stainier et al.,
1997). Surprisingly, these are also found on the Yersinia
virulon. LcrQ and YscM2 are 33% and 29% identical,
respectively, to YopH(1–129) (Fig. 6). Yersinia strains
containing lcrQ deletions secreted Yop effectors constitu-
tively at 378C independent of Ca21 concentration. It was
hypothesized that LcrQ may act as a negative repressor of
yop gene transcription (Rimpiläinen et al., 1992). Recently,
it was reported that SycH, the chaperone specific for
YopH, also binds to LcrQ and is necessary for its
translocation (Cambronne et al., 2000). The carboxy-
terminal regions of all three proteins are more homologous
than the amino-terminus (Fig. 6), suggesting that most of
LcrQ could fold like YopH. Hydrophobic residues in helix
a1 (positions 5, 8, 12 and 16) are conserved in all three
proteins. This suggests that the amphipathic nature of this
helix element may be a determinant for type III secretion.
There are two deletions in LcrQ and YscM2. One is a
seven-residue deletion (22–28) in the b1-strand. This may
suggest that these proteins cannot form dimers like YopH.
This region also contains two of the five positively charged
residues (Lys-26 and Arg-28) implicated in substrate
binding by YopH(1–129). The second deletion (residues
79–83) is at the end of helix a3 and includes Lys-82, which
forms a salt bridge to Asp-22. None of the surface residues
involved in the proposed YopH(1–129) substrate binding
site are conserved in the other two proteins, pointing to the
unique role of YopH for binding host cell substrates.
Discussion
The dimer may mimic the YopH:SycH interaction
In the crystal structure described here, the amino-terminal
domain of YopH, residues 1–129, forms a domain-
swapped dimer in which residues 2–28 from one protein
molecule associate almost exclusively with another
molecule related by a crystallographic dyad (1808
Fig. 6. Sequence alignment of YopH(1–129) with two homologous proteins. The sequences are YopH (Y. pseudotuberculosis ), LcrQ (Y.
pseudotuberculosis; 33% identical) and YscM2 (Y. enterocolitica; 29% identical). YopH residues are coloured green if they are identical to LcrQ
and/or YscM2. The Y. pestis LcrQ gene is 100% identical to Y. pseudotuberculosis LcrQ, whereas Y. enterocolitica YscM1 is 99% identical.
Secondary structure designations of YopH(1–129) are displayed above the sequence alignment using the same colour scheme as in Fig. 1B. Alpha-
helices are depicted as cylinders and b-strands as arrows. Residues in blue had perturbed chemical shifts upon binding phosphopeptide. Residues
boxed in magenta are those that, when mutated, inhibited p130Cas binding (Montagna et al., 2001). Residues with a black dot make intersubunit
contacts in the YopH(1–129) dimer. Residue numbering is for YopH.
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rotation). Domain swaps have been observed in numerous
other proteins; recent examples include RNase A (Liu
et al., 2001), SH2 domain (Schiering et al., 2000) and Hsp-
33 (Vijayalakshmi et al., 2001). In some cases, three-
dimensional domain swapping can occur at high protein
concentration or through changes in pH, temperature or
buffer composition (Bennett et al., 1995). But there are
cases in which the dimer is physiologically important
(Newcomer, 2001) or implies biological function (e.g. Su
et al., 1998). Most probably, the YopH(1–129) dimer has
no physiological role in secretion, but the mode of
interaction suggests how the specific chaperone SycH
may bind to YopH.
The results presented here show that the recombinant
protein as purified can adopt a monomeric conformation in
solution and that it is the major species when the protein is
purified at pH 5.7. The NMR relaxation measurements in
phosphate buffer at pH 6.5 described here and a
forthcoming NMR structure determination of a phospho-
peptide complex (P. Khandelwal et al., in preparation) are
consistent with a monomeric form. The fold of the
monomeric form is identical to half the observed dimer
(as in Fig. 7A, see next page) and preserves most of the
intramolecular interactions observed in the dimer. Instead
of the main chain of the 10-residue b1-strand forming
hydrogen bonds to b1 of the other subunit in the dimer, the
monomeric structure has a tight turn at Gly-29 with b1
folding back on itself to form a two-stranded b-hairpin.
A dimeric form of YopH(1–129) also exists in solution,
as shown by the dynamic light scattering and gel filtration
analyses. The dimer in the crystal is topologically
intertwined (knotted); simply translating the two monomers
away from each other cannot separate the two subunits.
Considering the topology, the monomeric form of
YopH(1–129) must partially unfold before forming a
dimer. Such a scenario would require a1 to dissociate
from the core domain, the turn between a1 and b1 to open
and the meandering loop (33–49) between b1 and a2 to
unravel partially. In fact, the NMR relaxation data show
that extensive conformational exchange processes at the
milli- to microsecond timescale do occur in this region of
the monomeric form (residues 20–50), part of which is the
dimer cross-over strand (residues 23–31). It is concei-
vable that this region of the monomer adopts various
conformations in solution, including a partially unfolded
form, which could serve as an intermediate on the dimer-
folding pathway. We suspect that YopH as well as the
amino-terminal regions of other type III secreted proteins
are partially unfolded and/or flexible, and that this
conformation may be essential for biological function
(reviewed by Namba, 2001). Such conformations can
associate with other proteins, either specifically or non-
specifically, and may include chaperones, transcription
factors or components of the injectosome. For example,
FlgM, an antisigma factor secreted by the flagellar type III
system, has a disordered amino-terminus when studied by
solution NMR that becomes ordered upon binding to RNA
polymerase (Daughdrill et al., 1997; 1998).
With the previous points in mind, we suggest that the
YopH(1–129) dimer observed in the crystal might be
mimicking the interactions in the complex formed between
the amino-terminal region of YopH and its specific
chaperone SycH. SycH may immediately bind the exposed
hydrophobic regions on a nascent YopH polypeptide or in a
single, partially unfolded monomer. These regions in the
partially unfolded monomer include residues 5, 8, 12, 15
and 16 froma1, 25, 27, 31, 32 and 33 fromb1, 54, 55 and 59
from a2 and 110, 113, 117 and 121 from a4. The b1 and a2
regions are part of the polypeptide segment shown
previously to be essential for chaperone binding (Woestyn
et al., 1996). By binding to these surfaces, SycH prevents
YopH from aggregating with itself or other proteins, a
phenomenon that was observed in a sycH – mutant strain
of Yersinia (Woestyn et al., 1996). By binding to an
extended YopH(1–129), SycH may present the a1-helix
(containing the previously implicated secretion signal 1–
17) for docking on the ATPase (YscN in Yersinia ) and
subsequent threading through the injectosome. This may
promote further unfolding downstream during membrane
translocation. Note that the a1-helix and its similar
counterpart in LcrQ are amphipathic, a property previously
suggested in YopE to be the primary recognition element
for secretion (Lloyd et al., 2001).
SycH may also bind to the apparently flexible mean-
dering loop (35–49) and restrain its conformation. The
alignment in Fig. 6 indicates that this loop is also present in
LcrQ. Confirming the structural role of SycH and its mode
of binding to YopH or LcrQ must await structural
characterization of a complex.
Comparison with another YopH(1–129) structure
determination
During the preparation of this report, a crystal structure
was reported of a very similar construct of YopH(1–129)
(PDB entry 1HUF; Evdokimov et al., 2001). The crystal
space group, unit cell parameters, position of the molecule
in the unit cell and the overall structure of 1HUF are very
similar to that reported here. The only difference between
1HUF and the structure presented here is that the 1HUF
polypeptide was modelled as a compact monomer, with a
reverse g-turn centred on Gly-29 to form a b-hairpin (b1
and b2 in the 1HUF nomenclature). Otherwise, the two
crystal structures are identical (Fig. 7).
From these considerations, we propose that the electron
density in both crystal structures is most consistent with a
domain-swapped dimer rather than with a compact
monomer. The protein purified by Evdokimov et al.
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(2001) was crystallized with a pH 9 precipitant, which is
close to the pH 8.5 precipitant used in the present work.
From our observations, high pH and protein concentration
promote protein dimerization (J. Vijayalakshmi, unpub-
lished). Difference electron density maps were calculated
for the 1HUF structure using the deposited structure
factors in the Protein Data Bank (PDB entry r1hufsf) and
for the structure and data described in this report. In both
cases, residues 27–31 had been omitted and the model
refined by simulated annealing. Comparison of the location
of difference peaks showed them to be very similar (data not
shown). There was no positive electron density above 2s for
Gly-29 in a g-turn conformation in either structure. Moreover,
atoms from the 1HUF tight turn make several close and
improbable intermolecular contacts with those of the identical
turn in the symmetry-related molecule (e.g. the symmetry-
related Gly-29 a-carbons are 2.5 Å apart; asterisk in Fig. 7A).
This symmetry-related molecule in the present structure
corresponds to a subunit of the domain-swapped dimer
(Fig. 7B).
The phosphopeptide-binding surface
We have described solution NMR experiments that show
direct binding of a phosphopeptide to the amino-terminal
domain of YopH. This allowed mapping the residues
perturbed by binding, and these overlap three residues
previously identified by mutagenesis (Montagna et al.,
2001). Although the substrate-binding domain has no
structural homology to an SH2 domain, it appears to be
serving a similar role. The Crk-associated protein p130cas
previously identified as a YopH substrate (Black and
Bliska, 1997) contains < 15 Tyr-containing motifs (YxxP)
typical of the recognition sequence for the SH2 domain of
Fig. 7. Comparison of similar YopH(1–129)
crystal structures. The view in both images is
perpendicular to the crystallographic dyad
parallel to the b-axis (black symbol) and located
at x 1 12, z 1
1
4; in each of the unit cells. The
orientation and position of the molecule in the
unit cells are identical in (A) and (B). Without
superposition, the r.m.s.d. between main-chain
atoms is 0.37 Å for residues 3–27 and 31–125.
A. The 1HUF structure (Evdokimov et al., 2001)
modelled as a monomer (left) and its dyad-
related symmetry molecule (right). The asterisk
indicates the Gly-29 Ca of the b-turn that is
2.5 Å from its symmetry mate.
B. The swapped dimer structure (this work) with
b1-strands crossing between subunits.
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Crk (Birge et al., 1993; Sakai et al., 1994). The
phosphopeptide used in the NMR experiments is from
another YopH substrate that also contains this motif (Black
et al., 2000). It is envisaged that the amino-terminal
domain of YopH will bind to one of the phosphorylated
motifs and increase the apparent affinity or specificity of
the catalytic domain towards the phosphotyrosine of a
nearby motif (Black et al., 1998).
We have provided evidence that the phosphopeptide-
binding region is composed of residues from the a1-helix,
the b1-hairpin of a proposed monomer and Arg-49 from
the end of the meandering loop. The highly positive
charged surface is suitable for recognizing the substrates
of YopH that contain not only the negatively charged
phosphotyrosine but also other acidic residues nearby.
The NMR data do not show any global changes in line
width during the titration, so the possibility that the protein
unfolds to bind substrate is unlikely. It may, in fact, stabilize
the structure. Exactly how the phosphopeptide is
positioned with respect to this surface must await the
NMR structure of the peptide–protein complex (P.
Khandelwal et al., in preparation).
Experimental procedures
Purification and crystallization
Expression plasmid pYopH (Bliska and Black, 1995), modified
to encode residues 1–129 of Y. pseudotuberculosis YopH
fused to a Ser-(His)6 tag, was provided by Professor James
B. Bliska (State University of New York, Stony Brook, NY,
USA). Transformed E. coli BL21(DE3) cells were grown in LB
media, induced with 1 mM IPTG for 2 h at 378C and harvested
by centrifugation. Frozen cell pellets were resuspended in
lysis buffer containing 137 mM NaCl, 3 mM KCl, 10 mM
Na2HPO4, 2 mM KH2PO4, pH 7.4, and protease inhibitors:
aprotinin (0.05mg ml21), leupeptin (0.05mg ml21) and tosyl-
L-lysine chloromethyl ketone (0.5 mg ml21). Cells were lysed
by two passes through a French press (1200 p.s.i.) and
clarified by centrifugation at 20 400 g for 20 min. The
supernatant was mixed with 5 ml of Ni21-NTA matrix (Qiagen)
equilibrated in lysis buffer and rocked gently for 1 h at 48C.
After washing the gel three times with lysis buffer and three
times with lysis buffer containing 30 mM imidazole, the protein
was eluted with a linear gradient from 30 to 300 mM imidazole.
The protein was . 99% pure by SDS–gel electrophoresis.
Before crystallization, the protein was dialysed into 10 mM
NaCl, 1 mM EDTA, 0.1% b-mercaptoethanol, 10 mM imida-
zole, pH 7.2, and concentrated to 10 mg ml21 in a Centricon
10 (Millipore) at 48C. Drops containing 2ml of protein and 2ml
of precipitant [2–10% polyethylene glycol (PEG) 8000, 90–
100 mM NaCl, 100 mM Tris-HCl, pH 8.5] were equilibrated
against 1 ml of the same precipitant by vapour diffusion at
228C. Triangular crystals appeared in 24 h and grew to full size
(0.45 0.4 0.2 mm3) in 3–5 days. Crystals were of space
group C2221 with cell dimensions a¼ 47.9 Å, b¼120.7 Å,
c¼48.8 Å and one molecule per asymmetric unit.
For NMR studies, [15N, 13C]-YopH(1–129) was prepared
by growing bacteria in M9 minimal media supplemented with
[13C]-glucose and 15NH4Cl. A
15N-labelled sample was
prepared using 15NH4Cl. Protein was purified as above,
dialysed into sample buffer (5% 2H2O, 0.05% NaN3, 50 mM
sodium phosphate, pH 6.5) and concentrated to 0.8–0.9 mM.
Data collection
Before data collection, crystals in stabilizing solution (10%
PEG 8000, 90 mM NaCl, 100 mM Tris-HCl, pH 8.6) were
transferred to the same solution containing 20% 2-methyl,
2,4-pentanediol for 3–5 min and frozen with cold nitrogen gas
generated by the X-stream system (Molecular Structure).
HgCl2 and UO2Cl2 derivative and native intensity data were
measured with an R-AXIS IV (Rigaku) detector using X-rays
generated by an RU-3-HR running at 50 kV, 100 mA and
double focusing mirrors (Molecular Structure). Platinum
chloride derivative data were collected at the LIII edge of
platinum using the Princeton CCD detector at beamline F2,
Cornell High Energy Synchrotron Source. Images were
processed with the HKL package (Otwinowski and Minor,
1997) and the CCP4 system (Bailey, 1994).
Phasing and refinement
Heavy atom sites for the platinum derivative were located in
isomorphous and anomalous difference Patterson maps.
Binding sites for the other derivatives (HgCl2 and UO2Cl2)
were determined by difference Fourier methods. The heavy
atom positions were refined and the MIRAS phases
calculated with MLPHARE (Bailey, 1994). Solvent flattening
and histogram matching with DM improved the phases. The
initial chain trace into 3.0 Å solvent-flattened maps located all
secondary structural elements. Successive rounds of model
building with the program O (Jones et al., 1991), refinement of
the partial structure with X-PLOR and phase combination using
SIGMAA (Read, 1986) allowed for an unambiguous tracing of
the protein from residues 2–125. Omit maps helped to clarify
the domain swap at the crystallographic twofold (Fig. 1C). The
model, including a bulk solvent term and 110 water molecules,
was refined to 2.2 Å resolution with good stereochemistry.
Residues 126–136, which include the (His)6 tag, were not
visible in the electron density and believed to be disordered.
Refinement statistics are presented in Table 1. Co-ordinates
and structure factors have been deposited in the Protein Data
Bank (http://www.rcsb.org; accession code 1 K46). Figures
were prepared with RIBBONS (Carson, 1997), O (Jones et al.,
1991), MCMOLW and MCSHOWCASE (McRee, 1996) and GRASP
(Nicholls et al., 1991).
Purification of YopH(1–129) monomer
The monomeric form of YopH(1–129) was expressed from
the same plasmid described above, but purified by a
procedure similar to that reported for the full-length YopH
(Zhang et al., 1992). Cell pellets were suspended in 100 mM
NaCl, 1 mM EDTA, 0.1% b-mercaptoethanol (v/v), 100 mM
sodium acetate, pH 5.7. Cleared lysates were added to a CM-
Sepharose cation exchange column. The column was washed
twice with 300 mM NaCl in acetate buffer and eluted with a
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linear 0.5–1.5 M NaCl gradient. Pure fractions were collected,
concentrated and dialysed in 10 mM NaCl, 1 mM EDTA, 0.1%
b-mercaptoethanol, 10 mM sodium acetate, pH 5.7. The
protein was applied to a Superdex HR 75 10/30 gel filtration
column (Amersham Pharmacia Biotech) and eluted with the
same buffer. The apparent molecular weights of the eluted
peaks were estimated by comparison with elution volumes of
protein standards. Dynamic light scattering was done with the
Dyna-Pro 801 (Protein Solutions). Apparent molecular
weights were derived from the hydrodynamic radius using
the manufacturer’s software.
NMR T1 and T2 relaxation measurements
NMR spectra for 15N spin relaxation measurements and
peptide titrations were recorded on a Varian 800 MHz Inova
spectrometer at 258C, using a sample of < 0.9 mM in sodium
phosphate buffer, pH 6.5. 1H, 15N and 13C chemical shifts
were assigned to backbone and side-chain atoms as
described previously (Khandelwal et al., 2001). T1 relaxation
times were measured according to established methods
(Dayie and Wagner, 1994). The T2 experiment was recorded
as published (Dayie and Wagner, 1994), with the modification
that only a single 15N refocusing pulse and continuous proton
decoupling were used in the T2 measuring period (Wang et al.,
2001). Without the CPMG or spin-lock sequence, confor-
mational exchange broadening, signifying milli- and micro-
second dynamics, was maximally preserved. All experiments
were recorded as 128*4096 complex matrices with 16 scans
per complex t1 point and spectral width of 3000 Hz and
15009 Hz in the F1 and F2 dimensions with recycle delay of
1 s. For T1 measurements, 15 inversion recovery delays
varying from 10 to 1100 ms were used. Fourteen transverse
relaxation delays from 10 to 100 ms were used for T2
measurements. Duplicate experiments were recorded for a
few delays. The spectra were processed and analysed using
NMRPIPE (Delaglio et al., 1995) and NMRVIEW (Johnson and
Blevins, 1994) respectively. The relaxation rates were
obtained from non-linear fits of single exponential functions
for longitudinal and transverse relaxation.
Peptide titration using HSQC experiments
To assess phosphopeptide binding to YopH(1–129), two-
dimensional 1H–15N HSQC spectra were collected at
increasing concentrations of the peptide acetyl-
DE(pY)DDPF-amide (synthesized at the University of
Michigan Protein Structure Facility). Aliquots of a 12 mM
peptide solution in water were added to 840ml of 0.9 mM
protein solution to give peptide–protein molar ratios of 0.07,
0.15, 0.30, 0.45, 0.61, 0.76, 0.91, 1.06 and 1.2. The 15N–1H
HSQC spectra were overlaid, and peaks that changed their
chemical shifts in a continuous fashion (fast/intermediate
exchange) were identified. In addition, resonances for the
peptide complex were assigned independently of the
apoprotein (Khandelwal et al., 2001), which allowed the
identification of the titrating residues in intermediate/slow
exchange. Residues were defined as perturbed upon peptide
binding if the chemical shift of two nuclei had changed
significantly between complex and apoprotein.
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